Dr. Richard Hotchkiss and Dr. John DiPersio co-authored a paper in the New England Journal of Medicine highlighting a promising strategy that could help improve the efficacy of cancer immunotherapies.
New WashU Medicine study aims to extend the life of cancer immunotherapy








